Current and detailed coverage of the latest antibiotic & antiviral drug developments worldwide
How things change. Twenty years ago the anti-infective sector was characterised by new issues of largely derivative products and antivirals with specific therapeutic action. Over time, though, the area has become one of the most attractive with many issues reaching the popular press - eg AIDS/HIV, greater disease resistance to antibiotics and the controversy surrounding the novel new influenza treatments.
The amount of information around is bewildering which is why busy executives will appreciate Anti - Infective News (AIN).
AIN makes tracking drug & company developments in the anti-infective area easy. Every 36+ page issue is comprehensively indexed and packed with key information on:
News by anti-infective sector
R&D, product and agreement news by anti-infective type including:
Antibacterials
Antifungals
Anti mycobacterials
Antivirals
HIV/AIDS
Antiprotozoals/ antianthelmintics.
General Development News
R&D, product and agreement news for non-condition specific anti-infective agents.
Conference Listings
A round up of upcoming meetings, conferences and seminars.
Anti-Infective Drug News published by Espicom Business Intelligence. This newsletter price starts from US $ 1095.
